NR606 Week 5 Exam V2 | NR606 Diagnosis
& Management in Psychiatric-Mental
Health II Practicum | Q&A with Rationale
(NR606 Week 5 Exam) | Chamberlain
University
1. A 9-year-old male is diagnosed with ADHD, combined type. Which of the following is
considered a first-line pharmacological treatment according to clinical guidelines?
A. Methylphenidate
B. Atomoxetine
C. Guanfacine
D. Bupropion
Answer: A
Rationale: Stimulants like methylphenidate are the first-line treatment for ADHD in
school-age children because of their high efficacy rates. Non-stimulants like Atomoxetine
are typically considered second-line or used when there is a contraindication to stimulants.
Treatment should always be part of a comprehensive plan that includes behavioral
interventions.
2. When evaluating a 14-year-old for Major Depressive Disorder, which symptom is more
commonly seen in adolescents than in adults?
A. Irritable mood
,B. Hypersomnia
C. Psychomotor retardation
D. Early morning awakening
Answer: A
Rationale: In children and adolescents, an irritable mood can satisfy the DSM-5-TR
diagnostic criteria for a major depressive episode instead of a depressed mood. Adults are
more likely to present with overt sadness or anhedonia. Recognizing irritability as a
symptom of depression is crucial for accurate diagnosis in pediatric populations.
3. Which FDA-approved medication is indicated for the treatment of depression in children as
young as 8 years old?
A. Sertraline
B. Escitalopram
C. Paroxetine
D. Fluoxetine
Answer: D
Rationale: Fluoxetine is currently the only SSRI with FDA approval for treating MDD in
children aged 8 and older. Escitalopram is approved for MDD in adolescents aged 12 to 17.
Close monitoring for suicidal ideation is required for all pediatric patients starting
antidepressant therapy.
, 4. A 5-year-old child presents with repetitive motor movements and a persistent deficit in
social communication. Which screening tool is most appropriate?
A. PHQ-9
B. Vanderbilt Assessment Scale
C. M-CHAT-R/F
D. SCARED
Answer: C
Rationale: The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-
CHAT-R/F) is a validated tool for screening Autism Spectrum Disorder. It is typically used
for children between 16 and 30 months of age, but its principles apply to early
developmental screening. Positive screens should lead to a comprehensive diagnostic
evaluation by a specialist.
5. What is the primary mechanism of action for Atomoxetine (Strattera) in the treatment of
ADHD?
A. Dopamine reuptake inhibition
B. Alpha-2 adrenergic agonist
C. Serotonin-Norepinephrine reuptake inhibition
D. Selective norepinephrine reuptake inhibition
Answer: D
& Management in Psychiatric-Mental
Health II Practicum | Q&A with Rationale
(NR606 Week 5 Exam) | Chamberlain
University
1. A 9-year-old male is diagnosed with ADHD, combined type. Which of the following is
considered a first-line pharmacological treatment according to clinical guidelines?
A. Methylphenidate
B. Atomoxetine
C. Guanfacine
D. Bupropion
Answer: A
Rationale: Stimulants like methylphenidate are the first-line treatment for ADHD in
school-age children because of their high efficacy rates. Non-stimulants like Atomoxetine
are typically considered second-line or used when there is a contraindication to stimulants.
Treatment should always be part of a comprehensive plan that includes behavioral
interventions.
2. When evaluating a 14-year-old for Major Depressive Disorder, which symptom is more
commonly seen in adolescents than in adults?
A. Irritable mood
,B. Hypersomnia
C. Psychomotor retardation
D. Early morning awakening
Answer: A
Rationale: In children and adolescents, an irritable mood can satisfy the DSM-5-TR
diagnostic criteria for a major depressive episode instead of a depressed mood. Adults are
more likely to present with overt sadness or anhedonia. Recognizing irritability as a
symptom of depression is crucial for accurate diagnosis in pediatric populations.
3. Which FDA-approved medication is indicated for the treatment of depression in children as
young as 8 years old?
A. Sertraline
B. Escitalopram
C. Paroxetine
D. Fluoxetine
Answer: D
Rationale: Fluoxetine is currently the only SSRI with FDA approval for treating MDD in
children aged 8 and older. Escitalopram is approved for MDD in adolescents aged 12 to 17.
Close monitoring for suicidal ideation is required for all pediatric patients starting
antidepressant therapy.
, 4. A 5-year-old child presents with repetitive motor movements and a persistent deficit in
social communication. Which screening tool is most appropriate?
A. PHQ-9
B. Vanderbilt Assessment Scale
C. M-CHAT-R/F
D. SCARED
Answer: C
Rationale: The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-
CHAT-R/F) is a validated tool for screening Autism Spectrum Disorder. It is typically used
for children between 16 and 30 months of age, but its principles apply to early
developmental screening. Positive screens should lead to a comprehensive diagnostic
evaluation by a specialist.
5. What is the primary mechanism of action for Atomoxetine (Strattera) in the treatment of
ADHD?
A. Dopamine reuptake inhibition
B. Alpha-2 adrenergic agonist
C. Serotonin-Norepinephrine reuptake inhibition
D. Selective norepinephrine reuptake inhibition
Answer: D
